本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Adverum Biotechnologies, Inc.

2.22
-0.0400-1.77%
盤後2.22-0.0050-0.23%16:04 EDT
成交量:16.19萬
成交額:35.88萬
市值:4,637.74萬
市盈率:-0.31
高:2.29
開:2.24
低:2.15
收:2.26
資料載入中...
2022/05/12

重要事件披露

8-K - Current report
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/29

重要事件披露

8-K - Current report
2022/03/29

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/21

重要事件披露

8-K - Current report
2021/12/08

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/12/08

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/09

重要事件披露

8-K - Current report
2021/08/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/11

重要事件披露

8-K - Current report
2021/08/05

重要事件披露

8-K - Current report
2021/08/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]